Sleep disorders, obesity, and aging

The role of orexin

Joshua P. Nixon, Vijayakumar Mavanji, Tammy A. Butterick, Charles J. Billington, Catherine M. Kotz, Jennifer A Teske

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The hypothalamic neuropeptides orexin A and B (hypocretin 1 and 2) are important homeostatic mediators of central control of energy metabolism and maintenance of sleep/wake states. Dysregulation or loss of orexin signaling has been linked to narcolepsy, obesity, and age-related disorders. In this review, we present an overview of our current understanding of orexin function, focusing on sleep disorders, energy balance, and aging, in both rodents and humans. We first discuss animal models used in studies of obesity and sleep, including loss of function using transgenic or viral-mediated approaches, gain of function models using exogenous delivery of orexin receptor agonist, and naturally-occurring models in which orexin responsiveness varies by individual. We next explore rodent models of orexin in aging, presenting evidence that orexin loss contributes to age-related changes in sleep and energy balance. In the next section, we focus on clinical importance of orexin in human obesity, sleep, and aging. We include discussion of orexin loss in narcolepsy and potential importance of orexin in insomnia, correlations between animal and human studies of age-related decline, and evidence for orexin involvement in age-related changes in cognitive performance. Finally, we present a summary of recent studies of orexin in neurodegenerative disease. We conclude that orexin acts as an integrative homeostatic signal influencing numerous brain regions, and that this pivotal role results in potential dysregulation of multiple physiological processes when orexin signaling is disrupted or lost.

Original languageEnglish (US)
Pages (from-to)63-73
Number of pages11
JournalAgeing Research Reviews
Volume20
DOIs
StatePublished - Mar 1 2015

Fingerprint

Sleep
Obesity
Aging of materials
Narcolepsy
Rodentia
Energy balance
Orexin Receptors
Physiological Phenomena
Animals
Neurodegenerative diseases
Sleep Initiation and Maintenance Disorders
Neuropeptides
Neurodegenerative Diseases
Energy Metabolism
Animal Models
Maintenance
Brain
Sleep Wake Disorders
Orexins

Keywords

  • Aging
  • Energy balance
  • Hypocretin
  • Obesity
  • Orexin
  • Sleep

ASJC Scopus subject areas

  • Aging
  • Biochemistry
  • Biotechnology
  • Molecular Biology
  • Neurology

Cite this

Nixon, J. P., Mavanji, V., Butterick, T. A., Billington, C. J., Kotz, C. M., & Teske, J. A. (2015). Sleep disorders, obesity, and aging: The role of orexin. Ageing Research Reviews, 20, 63-73. https://doi.org/10.1016/j.arr.2014.11.001

Sleep disorders, obesity, and aging : The role of orexin. / Nixon, Joshua P.; Mavanji, Vijayakumar; Butterick, Tammy A.; Billington, Charles J.; Kotz, Catherine M.; Teske, Jennifer A.

In: Ageing Research Reviews, Vol. 20, 01.03.2015, p. 63-73.

Research output: Contribution to journalArticle

Nixon, JP, Mavanji, V, Butterick, TA, Billington, CJ, Kotz, CM & Teske, JA 2015, 'Sleep disorders, obesity, and aging: The role of orexin', Ageing Research Reviews, vol. 20, pp. 63-73. https://doi.org/10.1016/j.arr.2014.11.001
Nixon, Joshua P. ; Mavanji, Vijayakumar ; Butterick, Tammy A. ; Billington, Charles J. ; Kotz, Catherine M. ; Teske, Jennifer A. / Sleep disorders, obesity, and aging : The role of orexin. In: Ageing Research Reviews. 2015 ; Vol. 20. pp. 63-73.
@article{a86a824a81b44ea4bcdf60ffe94d349c,
title = "Sleep disorders, obesity, and aging: The role of orexin",
abstract = "The hypothalamic neuropeptides orexin A and B (hypocretin 1 and 2) are important homeostatic mediators of central control of energy metabolism and maintenance of sleep/wake states. Dysregulation or loss of orexin signaling has been linked to narcolepsy, obesity, and age-related disorders. In this review, we present an overview of our current understanding of orexin function, focusing on sleep disorders, energy balance, and aging, in both rodents and humans. We first discuss animal models used in studies of obesity and sleep, including loss of function using transgenic or viral-mediated approaches, gain of function models using exogenous delivery of orexin receptor agonist, and naturally-occurring models in which orexin responsiveness varies by individual. We next explore rodent models of orexin in aging, presenting evidence that orexin loss contributes to age-related changes in sleep and energy balance. In the next section, we focus on clinical importance of orexin in human obesity, sleep, and aging. We include discussion of orexin loss in narcolepsy and potential importance of orexin in insomnia, correlations between animal and human studies of age-related decline, and evidence for orexin involvement in age-related changes in cognitive performance. Finally, we present a summary of recent studies of orexin in neurodegenerative disease. We conclude that orexin acts as an integrative homeostatic signal influencing numerous brain regions, and that this pivotal role results in potential dysregulation of multiple physiological processes when orexin signaling is disrupted or lost.",
keywords = "Aging, Energy balance, Hypocretin, Obesity, Orexin, Sleep",
author = "Nixon, {Joshua P.} and Vijayakumar Mavanji and Butterick, {Tammy A.} and Billington, {Charles J.} and Kotz, {Catherine M.} and Teske, {Jennifer A}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.arr.2014.11.001",
language = "English (US)",
volume = "20",
pages = "63--73",
journal = "Ageing Research Reviews",
issn = "1568-1637",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Sleep disorders, obesity, and aging

T2 - The role of orexin

AU - Nixon, Joshua P.

AU - Mavanji, Vijayakumar

AU - Butterick, Tammy A.

AU - Billington, Charles J.

AU - Kotz, Catherine M.

AU - Teske, Jennifer A

PY - 2015/3/1

Y1 - 2015/3/1

N2 - The hypothalamic neuropeptides orexin A and B (hypocretin 1 and 2) are important homeostatic mediators of central control of energy metabolism and maintenance of sleep/wake states. Dysregulation or loss of orexin signaling has been linked to narcolepsy, obesity, and age-related disorders. In this review, we present an overview of our current understanding of orexin function, focusing on sleep disorders, energy balance, and aging, in both rodents and humans. We first discuss animal models used in studies of obesity and sleep, including loss of function using transgenic or viral-mediated approaches, gain of function models using exogenous delivery of orexin receptor agonist, and naturally-occurring models in which orexin responsiveness varies by individual. We next explore rodent models of orexin in aging, presenting evidence that orexin loss contributes to age-related changes in sleep and energy balance. In the next section, we focus on clinical importance of orexin in human obesity, sleep, and aging. We include discussion of orexin loss in narcolepsy and potential importance of orexin in insomnia, correlations between animal and human studies of age-related decline, and evidence for orexin involvement in age-related changes in cognitive performance. Finally, we present a summary of recent studies of orexin in neurodegenerative disease. We conclude that orexin acts as an integrative homeostatic signal influencing numerous brain regions, and that this pivotal role results in potential dysregulation of multiple physiological processes when orexin signaling is disrupted or lost.

AB - The hypothalamic neuropeptides orexin A and B (hypocretin 1 and 2) are important homeostatic mediators of central control of energy metabolism and maintenance of sleep/wake states. Dysregulation or loss of orexin signaling has been linked to narcolepsy, obesity, and age-related disorders. In this review, we present an overview of our current understanding of orexin function, focusing on sleep disorders, energy balance, and aging, in both rodents and humans. We first discuss animal models used in studies of obesity and sleep, including loss of function using transgenic or viral-mediated approaches, gain of function models using exogenous delivery of orexin receptor agonist, and naturally-occurring models in which orexin responsiveness varies by individual. We next explore rodent models of orexin in aging, presenting evidence that orexin loss contributes to age-related changes in sleep and energy balance. In the next section, we focus on clinical importance of orexin in human obesity, sleep, and aging. We include discussion of orexin loss in narcolepsy and potential importance of orexin in insomnia, correlations between animal and human studies of age-related decline, and evidence for orexin involvement in age-related changes in cognitive performance. Finally, we present a summary of recent studies of orexin in neurodegenerative disease. We conclude that orexin acts as an integrative homeostatic signal influencing numerous brain regions, and that this pivotal role results in potential dysregulation of multiple physiological processes when orexin signaling is disrupted or lost.

KW - Aging

KW - Energy balance

KW - Hypocretin

KW - Obesity

KW - Orexin

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=84923350841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923350841&partnerID=8YFLogxK

U2 - 10.1016/j.arr.2014.11.001

DO - 10.1016/j.arr.2014.11.001

M3 - Article

VL - 20

SP - 63

EP - 73

JO - Ageing Research Reviews

JF - Ageing Research Reviews

SN - 1568-1637

ER -